Evaluation of Tropicamide-Phenylephrine Mydriatic Eye Drop Instillation on Choroidal Thickness.
EDI-OCT
OCT
choroid
choroidal thickness
phenylephrine
tropicamide
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
04 Oct 2023
04 Oct 2023
Historique:
received:
13
09
2023
revised:
26
09
2023
accepted:
27
09
2023
medline:
14
10
2023
pubmed:
14
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
The purpose of this study is to evaluate choroidal thickness (ChT) at the subfoveal and peripheral level after the instillation of 0.5% tropicamide + 10% phenylephrine 9 hydrochloride eye drops by using OCT scans in enhanced depth image (EDI) mode. In total, 53 patients (30 males and 23 females) were involved, and the mean age was 25.62 ± 2.41 (age range: 23-36). The dominant eye was treated with tropicamide + phenylephrine (Visumidriatic Fenil 100 mg/mL + 5 mg/mL, Visufarma) while the nondominant eye was used as the control. An OCT analysis was performed on both eyes before and 30 min after the instillation of a drop of mydriatic in the dominant eye. The ChT was measured by using the OCT software measurement tool (Spectralis; Heidelberg Engineering; Heidelberg, Germany, version 6.0). The results showed a statistically significant ChT decrease (
Identifiants
pubmed: 37834998
pii: jcm12196355
doi: 10.3390/jcm12196355
pmc: PMC10573589
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Ophthalmol. 2017 Dec 18;10(12):1870-1876
pubmed: 29259906
Eur J Ophthalmol. 2014 Nov-Dec;24(6):879-84
pubmed: 24729143
Graefes Arch Clin Exp Ophthalmol. 2020 Dec;258(12):2729-2736
pubmed: 32875394
Curr Eye Res. 2016 May;41(5):708-14
pubmed: 25860873
Ther Adv Ophthalmol. 2022 Nov 6;14:25158414221132825
pubmed: 36388726
Ophthalmology. 1999 Mar;106(3):440-1
pubmed: 10080195
Eye (Lond). 1990;4 ( Pt 2):255-61
pubmed: 2199235
J Clin Med. 2023 Apr 15;12(8):
pubmed: 37109228
Prog Retin Eye Res. 2010 Mar;29(2):144-68
pubmed: 20044062
JAMA Ophthalmol. 2021 Feb 1;139(2):182-188
pubmed: 33355613
Clin Exp Optom. 2009 Jan;92(1):2-8
pubmed: 18691218
J Refract Surg. 2023 Jan;39(1):68
pubmed: 36630434
Graefes Arch Clin Exp Ophthalmol. 2014 Dec;252(12):1871-83
pubmed: 25363655
J Ocul Pharmacol Ther. 2014 May;30(4):366-70
pubmed: 24476454
J Ophthalmol. 2019 Sep 29;2019:8079127
pubmed: 31662897
Sci Rep. 2021 Jan 21;11(1):2015
pubmed: 33479470
Ophthalmology. 1999 Mar;106(3):564-9
pubmed: 10080215
J Ophthalmol. 2015;2015:981274
pubmed: 26509080
Eye (Lond). 2021 Mar;35(3):913-918
pubmed: 32467635
Prog Retin Eye Res. 2010 Jan;29(1):1-18
pubmed: 19747980
Prog Retin Eye Res. 2018 May;64:96-130
pubmed: 29229444
Exp Eye Res. 2014 Nov;128:181-9
pubmed: 25304219
Sci Rep. 2021 Apr 26;11(1):8936
pubmed: 33903644
Eye (Lond). 2019 Nov;33(11):1741-1747
pubmed: 31164729
Ophthalmic Surg Lasers Imaging. 2011 Jul;42 Suppl:S75-84
pubmed: 21790115
Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):261-6
pubmed: 22167095
Sci Rep. 2022 Nov 7;12(1):18845
pubmed: 36344612
Saudi J Ophthalmol. 2022 Feb 18;35(2):108-111
pubmed: 35391812
Ophthalmology. 2013 Oct;120(10):2023-8
pubmed: 23697958
Optom Vis Sci. 2012 Aug;89(8):1150-5
pubmed: 22797514
PLoS One. 2020 Aug 25;15(8):e0237990
pubmed: 32841281
Exp Eye Res. 2006 Mar;82(3):357-61
pubmed: 16289045
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):38
pubmed: 32196096
J Ophthalmol. 2016;2016:7291257
pubmed: 26925259
Eye Contact Lens. 2011 May;37(3):140-4
pubmed: 21455079
J Ophthalmol. 2017;2017:2915261
pubmed: 28751980